{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:36:25Z","timestamp":1790044585250,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacl.2025.04.184","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:48:49Z","timestamp":1758602929000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S","title":["Identification and treatment of polycystic ovary syndrome in adolescents: A primer for the lipidologist"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7298-4959","authenticated-orcid":false,"given":"Sarah E.","family":"Swauger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Crimmins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.04.184_bib0001","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"issue":"11","key":"10.1016\/j.jacl.2025.04.184_bib0002","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.184_bib0004","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000375530","article-title":"The diagnosis of polycystic ovary syndrome during adolescence","volume":"83","author":"Witchel","year":"2015","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.184_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An International Consortium Update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.184_bib0006","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International Evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jacl.2025.04.184_bib0007","first-page":"533","article-title":"The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis","volume":"17","author":"Naz","year":"2019","journal-title":"Int J Reprod Biomed"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.184_bib0008","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","article-title":"Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis","volume":"191","author":"Neven","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.jacl.2025.04.184_bib0009","first-page":"2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.184_bib0010","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1210\/jc.2011-0225","article-title":"Approach to the girl with early onset of pubic hair","volume":"96","author":"Oberfield","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.184_bib0011","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-11-0223","article-title":"Premature adrenarche: novel lessons from early onset androgen excess","volume":"165","author":"Idkowiak","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.184_bib0012","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2023.02.006","article-title":"Adolescent PCOS: a postpubertal central obesity syndrome","volume":"29","author":"Ib\u00e1\u00f1ez","year":"2023","journal-title":"Trends Mol Med"},{"issue":"7","key":"10.1016\/j.jacl.2025.04.184_bib0013","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1530\/EC-21-0118","article-title":"Predictive factors of polycystic ovary syndrome in girls with precocious pubarche","volume":"10","author":"Guarnotta","year":"2021","journal-title":"Endocr Connect"},{"issue":"11","key":"10.1016\/j.jacl.2025.04.184_bib0014","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.184_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.184_bib0016","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diacare.11.6.500","article-title":"Selective insulin action on skin, ovary, and heart in insulin-resistant states","volume":"11","author":"Geffner","year":"1988","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jacl.2025.04.184_bib0017","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","article-title":"Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor","volume":"80","author":"Willis","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2025.04.184_bib0019","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-04077-8","article-title":"Visceral adipose tissue, epicardial fat, and hepatic steatosis in polycystic ovary syndrome: a study of ectopic fat stores and metabolic dysfunction","author":"de Melo Cavalcante","year":"2024","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.184_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/1464727022000198952","article-title":"Polycystic ovary syndrome and fat distribution: the central issue?","volume":"5","author":"Lord","year":"2002","journal-title":"Hum Fertil (Camb)"},{"issue":"8","key":"10.1016\/j.jacl.2025.04.184_bib0021","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrendo.2014.58","article-title":"Hyperinsulinaemic androgen excess in adolescent girls","volume":"10","author":"Ib\u00e1\u00f1ez","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/jwh.2010.2053","article-title":"Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome","volume":"20","author":"Stovall","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-5448.2012.00902.x","article-title":"Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI","volume":"14","author":"Flannery","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0024","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.fertnstert.2014.04.004","article-title":"Assessment of insulin resistance in lean women with polycystic ovary syndrome","volume":"102","author":"Morciano","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14534-2","article-title":"Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome","volume":"7","author":"Deng","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.184_bib0026","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2018.10.020","article-title":"Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome","volume":"111","author":"Zore","year":"2019","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.jacl.2025.04.184_bib0027","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0029","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12902-022-01098-0","article-title":"Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity","volume":"22","author":"Gupta","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.184_bib0030","first-page":"372","article-title":"Relationship of inflammatory and metabolic parameters in adolescents with PCOS: BMI matched case-control study","volume":"66","author":"Ta\u015fk\u00f6m\u00fcr","year":"2022","journal-title":"Arch Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jacl.2025.04.184_bib0031","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.184_bib0032","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/jcm12020557","article-title":"The burden of non-alcoholic fatty liver disease in adolescents with polycystic ovary syndrome: a case-control study","volume":"12","author":"Giannouli","year":"2023","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jacl.2025.04.184_bib0033","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society Clinical Practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jacl.2025.04.184_bib0034","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.184_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpag.2011.01.002","article-title":"Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome","volume":"24","author":"Ornstein","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"11","key":"10.1016\/j.jacl.2025.04.184_bib0036","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"Lass","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.184_bib0037","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrendo.2013.149","article-title":"Lifestyle intervention in childhood obesity: changes and challenges","volume":"9","author":"Reinehr","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.184_bib0038","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis","volume":"137","author":"Al Khalifah","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.184_bib0039","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.184_bib0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.jacl.2025.04.184_bib0041","article-title":"Role of metformin in polycystic ovary syndrome (PCOS)-related infertility","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.184_bib0042","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/jcpt.12379","article-title":"Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013","volume":"41","author":"Wang","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.184_bib0043","article-title":"Comparative management methods for adolescents with polycystic ovarian syndrome: a systemic review","volume":"16","author":"Vadan","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.184_bib0044","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jadohealth.2017.04.010","article-title":"Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome","volume":"61","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"J Adolesc Health"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s13063-023-07593-6","volume":"24","author":"Garcia-Beltran","year":"2023","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0046","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","article-title":"Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial","volume":"35","author":"Nylander","year":"2017","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.184_bib0047","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Fr\u00f8ssing","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.184_bib0048","article-title":"Psychiatric comorbidities in hospitalized adolescents with polycystic ovary syndrome: a cross-sectional study using the national inpatient sample","volume":"26","author":"Trivedi","year":"2024","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.jacl.2025.04.184_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114532","article-title":"Binge eating symptomatology in adolescents with polycystic ovary syndrome","volume":"279","author":"Pehlivanturk-Kizilkan","year":"2024","journal-title":"Physiol Behav"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.184_bib0050","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s43032-023-01435-1","article-title":"Disordered eating in young women with polycystic ovary syndrome","volume":"31","author":"Y\u00fcksel","year":"2024","journal-title":"Reprod Sci"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T21:19:48Z","timestamp":1758835188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1933287425002582"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.04.184","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and treatment of polycystic ovary syndrome in adolescents: A primer for the lipidologist","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.04.184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}